Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Dr Serena Lucotti, who has been awarded 'Italy Made Me' prize for her DPhil project.

Dr Serena Lucotti, a postdoctoral researcher in the Mechanisms of Metastasis research group, has been awarded an Italy Made Me prize for her DPhil project entitled: ‘Targeting prostanoid biosynthesis during metastasis: the therapeutic potential of aspirin and beyond’.

During her DPhil, Serena studied the effect of aspirin and other anti-platelet drugs on cancer metastasis, which led her to discover a novel platelet signalling pathway that supports tumour cell dissemination through the bloodstream. Her work identifies new targets and therapeutic opportunities for the prevention of metastasis in cancer patients.

Serena received her award from the Ambassador, Raffaele Trombetta, at a ceremony at the Italian Embassy on 4th September. 

The Italy Made Me award recognises UK-based Italian researchers who received part of their training in Italy. There are prizes for innovative research in three categories: Life Sciences, Physical and Engineering Sciences, Social Sciences and Humanities. It is coordinated by the Italian Embassy in London, in collaboration with Il Circolo, the “Association of Italian Scientists in the United Kingdom” (AISUK) and other Italian academic associations in the UK.

Similar stories

Machine Learning Enhances Detection of Multiple Cancer Types from Blood

Researchers from the University of Oxford have developed TriOx, a highly sensitive blood test that detects six cancers at their earliest stages. Published today in Nature Communications, the findings highlight the test’s potential to transform early cancer detection and improve patient outcomes.

Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer

The Oncology Department at the University of Oxford is excited to announce the forthcoming publication in the Proceedings of the National Academy of Sciences (PNAS) of the research paper “Goblet Cell Differentiation Subgroups in Colorectal Cancer.” This groundbreaking study sheds light on the role of goblet cell differentiation in colorectal cancer (CRC) and its impact on cancer progression and prognosis.

Ground-breaking Study reveals previously unknown genetic causes of Colorectal Cancer

A pioneering study, led by UK universities, including the University of Oxford, The Institute of Cancer Research, London, the University of Manchester and the University of Leeds, has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC).

Subashan Vadibeler wins 2024 Lasker Essay Contest

Subashan Vadibeler, a recent Oxford Rhodes scholar and Department of Oncology student, is one of five co-winners of the international 2024 Lasker Essay Contest, sponsored by the Lasker Foundation.

Glowing dye helps surgeons eradicate prostate cancer

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.

New funding for development of world's first lung cancer vaccine

Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.